Compare · BBLN vs HIMS
BBLN vs HIMS
Side-by-side comparison of Babylon Holdings Limited (BBLN) and Hims & Hers Health Inc. (HIMS): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both BBLN and HIMS operate in Medical/Nursing Services (Health Care), so they compete in similar markets.
- HIMS is the larger of the two at $7.60B, about 3.3x BBLN ($2.27B).
- HIMS has hit the wire 5 times in the past 4 weeks while BBLN has been quiet.
- HIMS has more recent analyst coverage (25 ratings vs 9 for BBLN).
- Company
- Babylon Holdings Limited
- Hims & Hers Health Inc.
- Price
- $0.55-13.27%
- $32.66-0.61%
- Market cap
- $2.27B
- $7.60B
- 1M return
- -
- +2.43%
- 1Y return
- -
- -31.38%
- Industry
- Medical/Nursing Services
- Medical/Nursing Services
- Exchange
- NYSE
- NYSE
- IPO
- 2019
- News (4w)
- 0
- 5
- Recent ratings
- 9
- 25
Babylon Holdings Limited
Babylon Holdings Limited operates as a digital healthcare company in the United Kingdom and internationally. Its digital-first platform provides with assistance to navigate the health system by connecting patients digitally to the clinicians. The company was founded in 2013 and is headquartered in London, the United Kingdom.
Hims & Hers Health Inc.
Hims & Hers Health, Inc. operates a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals. The company offers a range of health and wellness products and services available for purchase on its websites directly by customers. It provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, as well as cosmetics and supplement products, primarily focusing on wellness, sexual health, skincare, and hair care. The company's curated non-prescription products include vitamin C, melatonin, collagen protein, biotin, and teas in the wellness category; moisturizer, fragrances, face wash, and anti-wrinkle creams in the skincare category; condoms and lubricants in the sexual health category; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care category. It also offers medical consultation services; and engages in the wholesale of non-prescription product sales to retailers. Hims & Hers Health, Inc. is based in San Francisco, California.
Latest BBLN
- Babylon Holdings Limited filed SEC Form 8-K: Other Events
- Babylon Holdings Limited filed SEC Form 8-K: Other Events
- SEC Form NT 10-Q filed by Babylon Holdings Limited
- Babylon Holdings Limited filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
- Babylon Holdings Limited filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits
- SEC Form 25-NSE filed by Babylon Holdings Limited
- SEC Form 4 filed by Vnv Global Ab (Publ)
- SEC Form SC 13D/A filed by Babylon Holdings Limited (Amendment)
- SEC Form 4 filed by Vnv Global Ab (Publ)
- Babylon Holdings Announces Receipt Of Continued Listing Standards Notice From NYSE And Upcoming Delisting
Latest HIMS
- Hims & Hers Chief Accounting Officer, Irene Becklund, Announces Departure from the Company
- Hims & Hers Health Inc. filed SEC Form 8-K: Leadership Update
- Hims & Hers to Announce Second Quarter 2026 Financial Results on August 10, 2026
- Chief Financial Officer Okupe Oluyemi exercised 7,163 shares at a strike of $5.01 and sold $261,351 worth of shares (7,163 units at $36.49) as part of a pre-agreed trading plan (SEC Form 4)
- Hims & Hers Health Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits
- Chief Medical Officer Carroll Patrick Harrison sold $830,410 worth of shares (23,726 units at $35.00), decreasing direct ownership by 12% to 181,861 units (SEC Form 4)
- Chief Financial Officer Okupe Oluyemi exercised 6,376 shares at a strike of $5.01 and sold $619,217 worth of shares (18,197 units at $34.03) as part of a pre-agreed trading plan, decreasing direct ownership by 4% to 284,321 units (SEC Form 4)
- Chief Financial Officer Okupe Oluyemi converted options into 71,616 shares and covered exercise/tax liability with 39,541 shares, increasing direct ownership by 12% to 296,142 units (SEC Form 4) to cover withholding tax
- Chief Medical Officer Carroll Patrick Harrison converted options into 25,926 shares and covered exercise/tax liability with 8,310 shares, increasing direct ownership by 9% to 205,587 units (SEC Form 4) (withholding tax)
- Chief Operating Officer Chi Michael covered exercise/tax liability with 47,699 shares, sold $441,850 worth of shares (14,027 units at $31.50) as part of a pre-agreed trading plan and converted options into 86,264 shares, increasing direct ownership by 6% to 432,124 units (SEC Form 4) (withholding obligation)